GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer

Kristi D. Lynn, D. Gomika Udugamasooriya, Christina L. Roland, Diego H. Castrillon, Thomas J. Kodadek, Rolf A. Brekken

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences